Bei Akademie registrieren
GSK, GB00BN7SWP63

GSK stock pre-market at EUR 22.20: drugmaker ahead of Xetra open

Published on 10/19/2026 at 07:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GSK develops vaccines and medicines for human health markets. At Lang & Schwarz the stock trades pre-market at EUR 22.20 on October 19, 2026.

Business model and market setting

  • GSK develops vaccines and medicines for human health markets worldwide.
  • The FTSE 100 is the benchmark index for GSK’s United Kingdom home market.
  • GSK stock trades pre-market at EUR 22.20 at 7:35 a.m. CEST at Lang & Schwarz on October 19, 2026.
Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht
GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK researches and develops vaccines and medicines for human health markets worldwide, according to its investor materials. GSK stock trades pre-market at EUR 22.20 at 7:35 a.m. CEST at Lang & Schwarz on October 19, 2026.

Pre-market indication

The Lang & Schwarz indication was recorded during the pre-market period on October 19, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of GSK stock.

Business and market context

GSK’s business centers on vaccines and medicines, including products addressing infectious diseases, respiratory conditions and oncology. Market context: Market report FTSE 100.

More news and analysis on GSK stock

Disclaimer...
en | GB00BN7SWP63 | GSK | boerse | 70357325 | bgmi